Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

FOxTROT - Fluoropyrimidine, Oxaliplatin and Targeted Receptor Pre-Operative Therapy: a Controlled Trial in High-Risk Operable Colon Cancer

NCT00647530 is registered in ClinicalTrials.gov with University of Birmingham as lead sponsor.

NCT NCT00647530
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00647530 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
FOxTROT - Fluoropyrimidine, Oxaliplatin and Targeted Receptor Pre-Operative Therapy: a Controlled Trial in High-Risk Operable Colon Cancer
Lead sponsor
University of Birmingham
Phase
Phase 2/3
Overall status
Unknown status
Start date
May 15, 2008
Completion date
December 31, 2019
Enrollment
1,053 (actual)
Sites
10

Conditions

As the registry lists them; a condition with its own page is linked.

colorectal cancer